Literature DB >> 4565907

Favorable remission induction rate with twice weekly doses of L-asparaginase.

N Jaffe, D Traggis, L Das, G Frauenberger, H W Hann, B S Kim, Y Bishop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4565907

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.

Authors:  S-H Chen; D Pei; W Yang; C Cheng; S Jeha; N J Cox; W E Evans; C-H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2010-06-30       Impact factor: 6.875

2.  Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas.

Authors:  I Eggens; T J Ekström; F Aberg
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

3.  The lipid composition of highly differentiated human hepatomas, with special reference to fatty acids.

Authors:  I Eggens; L Bäckman; A Jakobsson; C Valtersson
Journal:  Br J Exp Pathol       Date:  1988-10

Review 4.  The interplay between metabolic remodeling and immune regulation in glioblastoma.

Authors:  Pravin Kesarwani; Shiva Kant; Antony Prabhu; Prakash Chinnaiyan
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

Review 5.  Arginase: Mechanisms and Clinical Application in Hematologic Malignancy.

Authors:  Zefan Du; Tianwen Li; Junbin Huang; Yun Chen; Chun Chen
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

6.  Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database.

Authors:  Zhiming Jiao; Zhanchun Feng; Ziqi Yan; Jinwen Zhang; Gang Li; Ganyi Wang; Qianyu Wang; Da Feng
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

7.  Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia.

Authors:  J R Roberson; H L Spraker; J Shelso; Y Zhou; H Inaba; M L Metzger; J E Rubnitz; R C Ribeiro; J T Sandlund; S Jeha; C-H Pui; S C Howard
Journal:  Leukemia       Date:  2008-10-16       Impact factor: 11.528

8.  [Extracorporeal treatment with L-asparaginase (author's transl)].

Authors:  H Pralle; H Löffler
Journal:  Blut       Date:  1977-09-29

Review 9.  Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.

Authors:  Melissa M Phillips; Michael T Sheaff; Peter W Szlosarek
Journal:  Cancer Res Treat       Date:  2013-12-31       Impact factor: 4.679

10.  Prevalence of transient hyperglycemia and diabetes mellitus in pediatric patients with acute leukemia.

Authors:  A Banihashem; A Ghasemi; N Ghaemi; N Moazzen; A Amirabadi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-02-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.